Bio-Rad Laboratories (BIO) was downgraded by Citigroup Inc. from "buy" to "neutral". They now have a $300.00 price target on the stock.
???????????????????? : ????????????2035????834?8000??????????CAGR11.9%?????????·??????????? [CNET News]
Digital PCR Market Size to Hit USD 35.32 Billion by 2035, Fueled by Rising Cancer Prevalence and Precision Oncology Demand – SNS Insider [Yahoo! Finance]
Bio-Rad Laboratories, Inc. (BIO) Achieves Modest Revenue Growth and Robust Free Cash Flow Growth [Yahoo! Finance]
Bio-Rad Reports Fourth-Quarter and Full-Year 2025 Financial Results